Korean Drug Co., Ltd. (KOSDAQ:014570)
3,390.00
-50.00 (-1.45%)
At close: Sep 11, 2026
Korean Drug Market Cap
Korean Drug has a market cap or net worth of 36.99 billion as of September 11, 2026. Its market cap has decreased by -25.98% in one year.
Market Cap
36.99B
Enterprise Value
676.81M
Revenue
65.39B
Ranking
n/a
PE Ratio
24.97
Stock Price
3,390.00
ChartMarket Cap Chart
Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 36.99B, an increase of 194.99%. That is a compound annual growth rate of 5.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 36.99B | -21.16% |
| Dec 30, 2025 | 46.92B | -6.42% |
| Dec 30, 2024 | 50.14B | -36.00% |
| Dec 28, 2023 | 78.35B | -8.30% |
| Dec 29, 2022 | 85.44B | -12.32% |
| Dec 30, 2021 | 97.44B | -13.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BL Pharmtech | 58.47B |
| RP Bio | 52.60B |
| Jin Yang Pharmaceutical | 51.12B |
| Organoidsciences | 43.80B |
| GeneBioTech Co. ,Ltd | 41.55B |
| Kyung Nam Pharm | 39.83B |
| Eagle Veterinary Technology Co.,Ltd | 39.63B |
| Korea Arlico Pharm | 38.01B |